Planisware's growth puts delivery work ahead of the AI revenue test
Planisware links stronger recurring growth partly to support staffing and completed customer implementations. Its Prisma AI product has a separate commercialization timetable.
What has to happen between winning a software customer and earning more recurring revenue? Planisware's October 23 results offer a practical answer: getting customers running, then having people available to support them.
In its original third-quarter release, the Euronext Paris-listed company, ticker PLNW, reported recurring revenue of €51.7 million, up 16.6% at constant currencies. Total revenue was €57.4 million. The currency-adjusted comparison holds exchange rates consistent; it does not measure growth attributable to AI.
The people behind recurring revenue
Planisware attributes stronger support activity partly to customers implemented earlier in the year and to reallocating Evolutive Support teams. Those teams had spent the first half handling a high volume of new-customer implementations.
That explanation makes staffing relevant to the growth story. A signed contract and a customer receiving an ongoing service are different operating stages. Moving people between those stages can affect which work gets completed and when it contributes.
Our reading is that implementation capacity deserves attention alongside new sales. More contracts can create more delivery work before they expand the base of customers receiving ongoing support. A recurring revenue label describes the business relationship; it does not mean the work needed to serve that relationship disappears.
The release does not isolate the revenue contribution of the staffing move. It would therefore be a stretch to credit the entire acceleration to reallocation, or to infer a productivity or margin improvement from revenue growth alone.
Prisma runs on another clock
Planisware says its Prisma AI agent entered beta at the end of Q3. It plans a commercial release by the end of Q1 2027 and expects direct revenue to begin progressively from then. That is management's timetable, with execution still ahead.
For investors, the distinction matters: evidence that the existing business is serving more customers cannot establish how quickly a new product will earn revenue. Testing a product, selling it and supporting paying users each require their own evidence.
The useful next questions are how customer implementations progress, whether support capacity keeps pace, and what Prisma's eventual commercial terms and paying adoption show. Today's results provide an operating explanation for existing growth. They leave the size and economics of the next AI revenue stream to future disclosures.